Discussion
A donor stem cell transplant and follow-up treatments helped a teenage girl achieve long-term remission from refractory immune thrombocytopenia (ITP), according to a case…
Four weekly injections of the antibody therapy daratumumab restored a key enzyme’s activity and triggered a two-year recovery for a woman with hard-to-treat immune-mediated thrombotic thrombocytopenic purpura (iTTP), according to a case report. In iTTP, the immune system produces antibodies that target the ADAMTS13 enzyme, preventing it from working…
Latest news & perspectives
Discussion
Discussion
Living with rare and chronic illnesses can be complicated, stressful, and draining. There are the obvious reasons, such as feeling sick, undergoing treatment, dealing with…
